26.12 USD
-0.13 (-0.5%)
26.12 USD
0 (0%)
Overall AMPH gets a fundamental rating of 6 out of 10. We evaluated AMPH against 190 industry peers in the Pharmaceuticals industry. While AMPH belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on AMPH. These ratings could make AMPH a good candidate for value investing.
1. Profitability
1.1 Basic Checks
- AMPH had positive earnings in the past year.
- In the past year AMPH had a positive cash flow from operations.
- Each year in the past 5 years AMPH has been profitable.
- Each year in the past 5 years AMPH had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of AMPH (6.70%) is better than 87.89% of its industry peers.
- With an excellent Return On Equity value of 14.37%, AMPH belongs to the best of the industry, outperforming 88.42% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 8.51%, AMPH belongs to the best of the industry, outperforming 86.84% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for AMPH is in line with the industry average of 12.83%.
- The 3 year average ROIC (12.92%) for AMPH is well above the current ROIC(8.51%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.7% | ||
| ROE | 14.37% | ||
| ROIC | 8.51% |
ROA(3y)10.51%
ROA(5y)8.2%
ROE(3y)20.19%
ROE(5y)14.97%
ROIC(3y)12.92%
ROIC(5y)10.14%
1.3 Margins
- Looking at the Profit Margin, with a value of 15.43%, AMPH belongs to the top of the industry, outperforming 87.37% of the companies in the same industry.
- AMPH's Profit Margin has improved in the last couple of years.
- AMPH's Operating Margin of 20.73% is amongst the best of the industry. AMPH outperforms 87.89% of its industry peers.
- In the last couple of years the Operating Margin of AMPH has grown nicely.
- The Gross Margin of AMPH (49.36%) is better than 64.21% of its industry peers.
- AMPH's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 20.73% | ||
| PM (TTM) | 15.43% | ||
| GM | 49.36% |
OM growth 3Y20.68%
OM growth 5YN/A
PM growth 3Y15.39%
PM growth 5Y7.52%
GM growth 3Y3.84%
GM growth 5Y4.54%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AMPH is creating some value.
- Compared to 1 year ago, AMPH has less shares outstanding
- AMPH has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, AMPH has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.39 indicates that AMPH is not a great score, but indicates only limited risk for bankruptcy at the moment.
- The Altman-Z score of AMPH (2.39) is better than 64.21% of its industry peers.
- The Debt to FCF ratio of AMPH is 5.49, which is a neutral value as it means it would take AMPH, 5.49 years of fcf income to pay off all of its debts.
- AMPH has a Debt to FCF ratio of 5.49. This is amongst the best in the industry. AMPH outperforms 82.11% of its industry peers.
- A Debt/Equity ratio of 0.78 indicates that AMPH is somewhat dependend on debt financing.
- AMPH has a Debt to Equity ratio of 0.78. This is in the lower half of the industry: AMPH underperforms 70.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.78 | ||
| Debt/FCF | 5.49 | ||
| Altman-Z | 2.39 |
ROIC/WACC0.95
WACC8.91%
2.3 Liquidity
- A Current Ratio of 3.12 indicates that AMPH has no problem at all paying its short term obligations.
- AMPH's Current ratio of 3.12 is in line compared to the rest of the industry. AMPH outperforms 53.68% of its industry peers.
- A Quick Ratio of 2.21 indicates that AMPH has no problem at all paying its short term obligations.
- AMPH has a Quick ratio of 2.21. This is comparable to the rest of the industry: AMPH outperforms 46.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.12 | ||
| Quick Ratio | 2.21 |
3. Growth
3.1 Past
- AMPH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.95%.
- Measured over the past years, AMPH shows a very strong growth in Earnings Per Share. The EPS has been growing by 61.62% on average per year.
- Looking at the last year, AMPH shows a decrease in Revenue. The Revenue has decreased by -0.03% in the last year.
- The Revenue has been growing by 17.82% on average over the past years. This is quite good.
EPS 1Y (TTM)-9.95%
EPS 3Y41.58%
EPS 5Y61.62%
EPS Q2Q%-3.12%
Revenue 1Y (TTM)-0.03%
Revenue growth 3Y18.69%
Revenue growth 5Y17.82%
Sales Q2Q%0.33%
3.2 Future
- Based on estimates for the next years, AMPH will show a small growth in Earnings Per Share. The EPS will grow by 0.14% on average per year.
- Based on estimates for the next years, AMPH will show a small growth in Revenue. The Revenue will grow by 4.14% on average per year.
EPS Next Y-8.73%
EPS Next 2Y-1.9%
EPS Next 3Y0.87%
EPS Next 5Y0.14%
Revenue Next Year-0.8%
Revenue Next 2Y1.99%
Revenue Next 3Y2.7%
Revenue Next 5Y4.14%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 7.59, the valuation of AMPH can be described as very cheap.
- Compared to the rest of the industry, the Price/Earnings ratio of AMPH indicates a rather cheap valuation: AMPH is cheaper than 93.16% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.60, AMPH is valued rather cheaply.
- AMPH is valuated cheaply with a Price/Forward Earnings ratio of 7.03.
- Based on the Price/Forward Earnings ratio, AMPH is valued cheaply inside the industry as 92.63% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 25.83. AMPH is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.59 | ||
| Fwd PE | 7.03 |
4.2 Price Multiples
- AMPH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMPH is cheaper than 91.05% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, AMPH is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.81 | ||
| EV/EBITDA | 7.27 |
4.3 Compensation for Growth
- AMPH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.12
EPS Next 2Y-1.9%
EPS Next 3Y0.87%
5. Dividend
5.1 Amount
- No dividends for AMPH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMPHASTAR PHARMACEUTICALS IN / AMPH FAQ
What is the fundamental rating for AMPH stock?
ChartMill assigns a fundamental rating of 6 / 10 to AMPH.
What is the valuation status of AMPHASTAR PHARMACEUTICALS IN (AMPH) stock?
ChartMill assigns a valuation rating of 8 / 10 to AMPHASTAR PHARMACEUTICALS IN (AMPH). This can be considered as Undervalued.
Can you provide the profitability details for AMPHASTAR PHARMACEUTICALS IN?
AMPHASTAR PHARMACEUTICALS IN (AMPH) has a profitability rating of 9 / 10.
What is the valuation of AMPHASTAR PHARMACEUTICALS IN based on its PE and PB ratios?
The Price/Earnings (PE) ratio for AMPHASTAR PHARMACEUTICALS IN (AMPH) is 7.59 and the Price/Book (PB) ratio is 1.55.